Choice Hotels is one of the hotel franchisors. The Company owns 6,500 hotels.
Regenxbio develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Federal Realty Investment Trust is an equity real estate investment trust specializing in the ownership, management, development and redevelopment of retail and mixed-use properties.
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome.
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
U.S. NeuroSurgical is a medical services company that partners with hospitals and physicians to own and operate facilities utilizing state-of-the-art and innovative technologies in medical treatment and/or diagnosis.
Cerecor is a clinical-stage biopharmaceutical company, which develops drugs to treat patients with neurological and psychiatric disorders.
CASI Pharmaceuticals focuses on building a pipeline through mutually beneficial business development transactions.
Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system.
Argan is a holding company primarily engaged in energy services.